Europe | Cafepharma

Bayer nabs new Eylea nod to help it toward 2015 sales target

Bayer nabs new Eylea nod to help it toward 2015 sales target

Fierce Pharma

retinal vein occlusion

Sanofi diabetes drug Toujeo wins European green light

Sanofi diabetes drug Toujeo wins European green light

Yahoo/Reuters

Novartis lung cancer drug gets EU recommendation

Novartis lung cancer drug gets EU recommendation

Yahoo/Reuters

If Pfizer's Right, Hospira Biosimilar Gold Rush Begins This Week

If Pfizer's Right, Hospira Biosimilar Gold Rush Begins This Week

Forbes

autoimmune disease

Gilead agrees 41,000 eur hep-C drug price for 12 week treatment

Gilead agrees 41,000 eur hep-C drug price for 12 week treatment

Yahoo/Reuters

Gilead Sciences

Gilead expects big increase in Europeans treated with hep C drug

Gilead expects big increase in Europeans treated with hep C drug

Yahoo/Reuters

Gilead Sciences

Gilead faces challenge to European patent on pricey hep C drug

Gilead faces challenge to European patent on pricey hep C drug

Yahoo/Reuters

Gilead Sciences

Orexigen Provides Progress Update on Mysimba European Marketing Authorization

Orexigen Provides Progress Update on Mysimba European Marketing Authorization

Yahoo

Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation

Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation

Drug Discovery and Development

EMA Recommends Hundreds of Drugs to be Suspended Over ‘Flawed Studies’

EMA Recommends Hundreds of Drugs to be Suspended Over ‘Flawed Studies’

WSJ Pharmalot

EC clears Boehringer Ingelheim's Ofev for idiopathic pulmonary fibrosis

EC clears Boehringer Ingelheim's Ofev for idiopathic pulmonary fibrosis

First Word Pharma

Boehringer Ingelheim

idiopathic pulmonary fibrosis

AbbVie’s hepatitis C drug gets European approval for sale

AbbVie’s hepatitis C drug gets European approval for sale

Marketwatch

Celgene: European Decision Not Best Case Scenario, Not Worst Case Either

Celgene: European Decision Not Best Case Scenario, Not Worst Case Either

Barron's

Orexigen diet pill recommended for approval in Europe

Orexigen diet pill recommended for approval in Europe

Yahoo/Reuters

AstraZeneca first-in-class ovarian cancer drug wins EU approval

AstraZeneca first-in-class ovarian cancer drug wins EU approval

Yahoo/Reuters

Celgene Hits 52-Week High on Positive CHMP Opinion

Celgene Hits 52-Week High on Positive CHMP Opinion

Yahoo/Zacks.com

Novartis says heart-failure drug wins faster review in Europe

Novartis says heart-failure drug wins faster review in Europe

Yahoo/Reuters

Once-weekly Lilly diabetes drug wins EU approval

Once-weekly Lilly diabetes drug wins EU approval

Yahoo/Reuters

Europe gives green light to AbbVie hepatitis C medicine, others

Europe gives green light to AbbVie hepatitis C medicine, others

Yahoo/Reuters

Boehringer Ingelheim

Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni

Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni

TheStreet.com

Gilead Sciences

1
2
3
4
5
6
7
8
9
…
next ›

Click here to subscribe to daily news headlines in your email inbox